| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |